Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 14, 2021
Patent Application Number
20180926
Date Filed
September 26, 2018
Patent abstract
This invention is directed to the treatment of cancer, particularly ocular melanoma, with a dual inhibitor of MET and VEGF such as Compound 1.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
